Statistics for A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation.
Total visits
| views | |
|---|---|
| A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation. | 182 |
Total visits per month
| views | |
|---|---|
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
File Visits
| views | |
|---|---|
| Arai_Sarantopoulos_CCR_2016_imatinib study.pdf | 193 |
Top country views
| views | |
|---|---|
| Germany | 37 |
| United Kingdom | 24 |
| United States | 17 |
| South Korea | 6 |
| China | 4 |
| Singapore | 4 |
| France | 1 |
| Indonesia | 1 |
| Netherlands | 1 |
Top city views
| views | |
|---|---|
| Kiez | 22 |
| Alexandria | 7 |
| Changi | 4 |
| Woodbridge | 3 |
| Beijing | 2 |
| Little Rock | 2 |
| Seoul | 2 |
| Suzhou | 2 |
| Winsted | 2 |
| Buffalo | 1 |
| Durham | 1 |
| Mountain View | 1 |
| Norwalk | 1 |
| Old Bridge | 1 |
| Overland Park | 1 |
| Seattle | 1 |
| Southampton | 1 |
| Yulee | 1 |